U.S. limits use of J&J's COVID vaccine on blood clot risks




  • In Health
  • 2022-05-05 21:38:39Z
  • By Reuters
 

(Reuters) -The U.S. health regulator said on Thursday it was limiting the use of Johnson & Johnson's COVID-19 vaccine for adults due to the risk of a rare blood clotting syndrome, the latest setback to the shot that has been eclipsed by rivals.

The J&J shot, which received U.S. clearance in February 2021 for adults, can be administered in cases where authorized or approved COVID-19 vaccines are not accessible or if an individual is less keen on using the other two shots, the Food and Drug Administration said.

J&J is one of the three vaccines in use in the United States. The other two are from Moderna and Pfizer.

The vaccine maker said it has updated the U.S. COVID-19 vaccine fact sheet to warn about the risk of thrombosis with thrombocytopenia syndrome (TTS), a rare but potentially life-threatening condition.

Use of the J&J shot has been weak in high-income countries, hurt by reports of rare, potentially deadly blood clots, production issues, including an accidental mix-up of ingredients by a contract manufacturer, and concerns about efficacy.

The drugmaker last month rescinded its forecast for COVID-19 vaccine sales, citing a glut of supply.

Cases of TTS, which involves blood clots accompanied by a low level of platelets, have previously been reported in recipients of the J&J vaccine.

The FDA in January amended the fact sheet for the J&J vaccine to include the risk of immune thrombocytopenia, months after the European Union's drugs regulator took similar action.

The FDA on Thursday said the risk of TTS warranted limiting the use of the single-dose shot after it conducted investigation of reported cases.

The U.S. Centers for Disease Control and Prevention in December had recommended that Americans choose to receive mRNA shots from Pfizer and Moderna over J&J's vaccine due to the rare cases of blood clotting.

Around 18.7 million Americans have received a J&J COVID-19 shot compared with 217.5 million people who received the Moderna vaccine and 340.6 million people who received Pfizer's shot, according to CDC.

(Reporting by Amruta Khandekar; Additional reporting by Rhea Binoy; Editing by Anil D'Silva, Shailesh Kuber and Uttaresh.V)

COMMENTS

More Related News

Pfizer says tweaked COVID-19 shots boost Omicron protection
Pfizer says tweaked COVID-19 shots boost Omicron protection

Pfizer says tweaking its COVID-19 vaccine to better target the Omicron variant is safe and boosts protection.

U.S. FDA declines to approve Spero
U.S. FDA declines to approve Spero's urinary tract infection drug
  • US
  • 2022-06-27 20:13:03Z

In the complete response letter, the health regulator concluded that Spero's late-stage study testing the drug was insufficient and an additional study would...

US grapples with whether to modify COVID vaccine for fall
US grapples with whether to modify COVID vaccine for fall

U.S. health authorities are facing a critical decision: whether to offer new COVID-19 booster shots this fall that are modified to better match recent changes of the shape-shifting coronavirus. Moderna and Pfizer have tested updated shots against the super-contagious omicron variant, and advisers to the Food and Drug Administration will debate Tuesday if it's time to make a switch - setting the stage for similar moves by other countries. "This is science at its toughest," FDA vaccine chief Dr. Peter Marks told The Associated Press, adding that a final decision is expected within days of the advisory panel's recommendation.

World Bank chief says inflation might last for two years, and some countries will find it
World Bank chief says inflation might last for two years, and some countries will find it 'very hard' to avoid recession

"Let the banks lend more," World Bank head David Malpass told the U.S. Federal Reserve.

Tale of 2 summits:
Tale of 2 summits: 'America's back' to America's backsliding
  • World
  • 2022-06-27 04:06:40Z

One year ago, Joe Biden strode into his first Group of Seven summit as president and confidently told the closest U.S. allies that "America is Back." Now...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health